Why $0 Prevention Beats High-Deductible Plans: The Copay Paradox

How the benefits industry's favorite cost-control lever is quietly costing employers millions

For fifteen years, the employee benefits industry has operated on what seemed like bulletproof logic: make employees pay more at the point of care, and they'll become smarter healthcare consumers.

Higher copays. Bigger deductibles. More "skin in the game."

The results are in. Patients cut back on the care they needed.

Nobody in the broker community likes to discuss what happened next: that $40 specialist copay you set to control costs is probably increasing your total healthcare spend.

The Theory That Sounded Brilliant (But Wasn't)

The logic seemed airtight:

• Higher copays → employees think twice before seeking care
• Employees thinking twice → fewer unnecessary visits
• Fewer visits → lower employer costs

Actuaries modeled it. Consultants sold it. CFOs approved it.

But everyone missed the fatal flaw.

Employees don't just skip unnecessary care. They also skip preventive care, and the downstream costs can be severe. The RAND Health Insurance Experiment, the largest study of cost-sharing ever run, found that patients who pay more cut effective and less effective care about equally, with the worst health effects concentrated in the sickest and poorest patients.

What Actually Happens (The Part Nobody Models)

When a $40 specialist copay goes into effect, the cascade looks like this:

Year 1: Utilization drops and claims costs dip. Your broker sends a congratulatory email. Your CFO is thrilled.

Years 2-3: Silent disasters accumulate beneath the surface:

• Your diabetic employees skip endocrinologist visits to avoid the $40 copay
• Hypertension patients don't follow up after starting new medications
• Employees with mental health conditions discontinue therapy (can't afford $40/week)
• Workers delay diagnostic imaging because $100 feels steep

Year 4: The employee who skipped three $40 follow-ups now files a $75,000 cardiac event claim.

The economics nobody calculated are simple: money saved on prevention copays tends to come back within a few years as higher-acuity claims.

The Actuarial Blind Spot

Traditional benefits models calculate immediate savings. They look at copay amounts multiplied by utilization reduction across all member months. Simple math that looks great in a spreadsheet.

What they should calculate is far more complex: immediate savings minus delayed high-acuity claims, minus productivity loss, minus the medication non-adherence cascade, minus emergency room substitution effects.

Why doesn't anyone run the second calculation?

Because the data lives in silos:

• Your medical claims processor doesn't track pharmacy adherence
• Your PBM doesn't see specialist visits
• Your carrier doesn't measure productivity loss
• Your wellness vendor lacks claims data

This fragmentation isn't accidental. It's profitable for everyone except the employer.

Value-Based Insurance Design Already Solved This

The approach this post describes has a name: value-based insurance design, or VBID. Health economists Michael Chernew, Allison Rosen, and Mark Fendrick defined it in 2007, arguing that cost-sharing should track a service's clinical value instead of being applied at the same rate to every service.

Connecticut Lowered Costs on Chronic Care

In 2011 Connecticut launched the Health Enhancement Program for state employees. The program follows VBID principles: it lowers patient costs for certain high-value primary care and chronic disease preventive services, and it requires enrollees to receive those services.

Employers That Zeroed Out High-Value Copays

Gulfstream Aerospace dropped its copay to zero for flu shots and for generic drugs used to treat certain chronic conditions. Colorado Springs School District 11, with 3,400 employees, redesigned its plan to push members away from open surgery when a minimally invasive alternative existed.

These programs share a common mechanism. They make the right care frictionless and add friction to care with less clinical value. The design question is settled. What remains is the incentive question that keeps most plans from adopting it.

The Math That Changes Everything

Let's model a 500-employee company over three years. I'll compare traditional cost-sharing versus zero-copay prevention to show you what most actuaries won't.

Traditional Model

• $30 PCP copay
• $40 specialist copay
• $100 imaging copay
• Preventive care participation: 34%
• Chronic condition visit adherence: 58%

Zero-Copay Prevention Model

• $0 for all preventive and chronic disease management
• Preventive care participation: 78%
• Chronic condition visit adherence: 89%

Projected 3-Year Costs:

ROI: 187% on the investment in zero-copay prevention.

You spend more on the front end and save multiples on the back end. That's healthcare economics most benefits consultants either don't understand or aren't incentivized to show you.

Why Your Broker Isn't Showing You This

Three uncomfortable truths:

1. Commission structures reward premium volume

Your broker often earns a percentage of total premium. Lower costs mean lower commissions, so they are not incentivized to reduce your spend. Some will protest that, but pull out your broker agreement and do the math yourself.

2. Carriers don't model long-term prevention ROI

They price on 12-month trend data. Prevention savings appear in years 2-4, after most policies renew. The carrier that would benefit from your lower claims three years from now might not even be your carrier anymore. So why would they invest in modeling it?

3. Implementation requires integrated data

Most brokers can't operationalize what they can't measure, and their systems weren't built for this. They're working with claims platforms that were state-of-the-art in 2003. Real-time prevention tracking requires modern infrastructure most simply don't have.

The Legal Framework That Enables This

What the Wellness Rules Allow

Group health plans can reward participants for taking part in programs designed to promote health or prevent disease. The rules grew out of HIPAA's nondiscrimination provisions and now sit in section 2705 of the Public Health Service Act, incorporated into ERISA section 715 and section 9815 of the Code. For health-contingent programs, the reward can't exceed 30% of the cost of coverage, or 50% for programs that target tobacco use. The program has to be reasonably designed to promote health or prevent disease, and participants who can't meet a standard need a reasonable alternative.

The design opportunity: Build the zero-copay structure as a wellness program where employees earn the copay waiver through specific actions:

• Completing annual physicals
• Participating in biometric screenings
• Adhering to chronic condition care plans

This creates a behavioral architecture where prevention becomes the path of least resistance. Nobody is forced into anything; the healthy choice simply becomes the easy choice. The plan document, the reward's value, and the eligibility rules all matter here. This is plan-design territory with real compliance exposure, so run the design past benefits counsel before launching.

ACA Mandates Create the Floor, Not the Ceiling

The Affordable Care Act mandates $0 cost-sharing for USPSTF Grade A and B preventive services. Most people assume that list is comprehensive, and it isn't.

What's covered at $0:

• Annual wellness visits
• Immunizations
• Cancer screenings
• Depression screening

What's NOT mandated (but should be $0):

• Follow-up visits after abnormal results
• Chronic disease management visits
• Mental health therapy continuation
• Physical therapy for chronic conditions

The gap between mandated prevention and care that genuinely prevents is where employers lose the most money. A mammogram is covered at $0, but the follow-up diagnostic ultrasound after a suspicious finding can run into the hundreds of dollars, applied against your deductible.

The HSA Catch: When $0 Copays Break Your Plan

One caveat keeps this advice from being universal: the health savings account. An HSA-qualified high-deductible health plan generally can't pay for care before the deductible is met, with a narrow exception for preventive care under IRC section 223(c)(2)(C).

That exception covered a short list of screenings and immunizations for years. In July 2019 the IRS issued Notice 2019-45, which lets an HSA-qualified HDHP cover fourteen specified services and items for specified chronic conditions before the deductible.

It isn't a blank check. A broad pre-deductible program for chronic disease management, physical therapy, or mental health therapy would break HSA eligibility and make employees' HSA contributions taxable. The University of Michigan's V-BID Center has pushed to expand the safe-harbor list, and a bipartisan bill introduced in February 2025, H.R. 3800, would codify Notice 2019-45 and let the list grow.

The zero-copay design works cleanly for non-HSA plans and for the services already on the preventive list. Employers running an HSA-qualified HDHP can apply it to preventive care now and should watch whether the chronic-care safe harbor expands. Broader $0 cost-sharing on chronic care may require moving off the HDHP/HSA design first, and that tradeoff belongs in the model before you commit.

Why This Only Works With Modern Technology

Zero-copay prevention models fail without the right infrastructure. You can't bolt this onto a legacy system and hope it works. Four pieces of infrastructure have to be in place:

1. Real-time eligibility verification

Employees must know before the appointment that it's covered at $0. Surprise bills kill trust and participation faster than anything. If someone gets a $40 bill for what they thought was free, they'll never engage with your wellness program again.

2. Automated care pathway logic

Your system must distinguish "preventive chronic care visit" from "acute sick visit" at the moment of claims adjudication. This requires sophisticated rules engines and real-time decision support, not batch processing that happens three days after the fact.

3. Closed-loop data integration

Medical, pharmacy, and lab data must flow bidirectionally. When someone fills a diabetes prescription, that should trigger outreach about scheduling their endocrinologist visit. When they complete that visit, it should update their pharmacy adherence tracking. None of this works if the systems can't talk to each other.

4. Transparent member experience

Employees need a portal showing what they've earned and what's available. Gamification drives sustained behavior change in healthcare the same way it does in consumer apps.

Most TPAs can't operationalize this because their claims systems were built when Bush was president. The first one, not the second one.

The Incentive Misalignments Blocking Progress

Why Carriers Don't Offer This Proactively

Fully insured carriers face a structural paradox. Under the medical loss ratio rules, their combined administrative costs and profit are capped at 15-20% of premium, depending on the market. When claims drop, the premium they collect drops with them, even though their administrative costs stay the same.

Their margin is built into the premium, and the premium follows the claims. The more efficiently your population uses healthcare, the less money they make. Some carriers have tried alternative payment models, but the underlying incentives don't change.

Why PBMs Actively Work Against This

Pharmacy benefit managers have made money through spread pricing (paying a pharmacy less than they bill the plan and keeping the difference), retaining a share of manufacturer rebates, and formulary steering toward higher-rebate drugs. Most commercial PBMs now pass the large majority of rebates back to plans, but spread pricing persists in many contracts, and the Department of Labor proposed new transparency rules for PBMs in January 2026.

Zero-copay prevention threatens all three revenue streams:

• Better medication adherence means fewer acute exacerbations, which means fewer high-cost specialty drugs
• Healthier populations mean lower overall prescription utilization
• Transparent pricing exposes spread

A PBM that profits from spread on high-cost specialty drugs loses revenue when a population needs fewer of those drugs. They're not going to recommend it. They might not even tell you it's possible.

The Implementation Roadmap

Phase 1: Diagnostic (Months 1-2)

Pull 24 months of claims data and analyze:

• Percentage of members skipping preventive care
• Chronic condition non-adherence rates
• Correlation between copay amounts and visit completion
• Emergency utilization patterns
• Specialty drug utilization for preventable conditions

Red flags indicating a copay problem:

• Less than 60% chronic disease visit adherence
• More than 15% of diabetics with gaps in specialist care
• Rising specialty Rx costs in preventable categories
• ER utilization well above your market's benchmark

If you see two or more of these, you've got a copay-induced preventive care crisis.

Phase 2: Pilot Design (Months 3-4)

Start with one condition. Don't try to revolutionize your entire benefits structure on day one.

Ideal pilot targets:

• Diabetes management: Clear ROI, measurable outcomes, well-established care protocols
• Hypertension control: Large population, straightforward interventions, immediate cost impact
• Mental health: Crisis conditions, obvious need, dramatic adherence improvements possible

Pilot structure:

• Eliminate copays for condition-specific care
• Require care plan enrollment (not optional; you're investing in them and they're committing to follow through)
• Track adherence and outcomes versus a matched control group
• Model 12-month cost impact with conservative assumptions

Phase 3: Technology Integration (Months 4-6)

This is where most pilots fail. You can have perfect plan design and enthusiastic employees, but if the technology doesn't support real-time execution, you're dead in the water.

You need:

• Real-time benefits checking at the point of care
• Provider portal for coverage verification
• Member app showing earned benefits and available services
• Automated claims adjudication rules that execute in real-time
• Data warehouse connecting medical, Rx, and lab data

If your TPA says "we'll handle this manually," find a new TPA. Manual processing means 30-60 day delays, frequent billing errors, provider confusion, and data gaps that prevent ROI analysis.

Phase 4: Measurement (Months 6-12)

Track these metrics religiously:

Engagement metrics:

• Care plan enrollment rate
• Visit adherence rate
• Preventive service completion rate

Clinical metrics:

• Biometric improvements (A1C, blood pressure, lipids)
• Medication adherence (PDC scores)
• Acute exacerbation rates

Financial metrics:

• PMPM cost trend versus control group
• ER/urgent care utilization change
• Specialty Rx trend
• Total cost of care per condition

Success threshold: 15% reduction in total cost of care over 12 months for the pilot condition.

Hit that? Scale it across your entire population.

The Emerging Health-to-Wealth Model

The next step in this evolution is where I think the industry is headed in the next few years.

A few innovators are asking a sharper question: what if zero-copay preventive care saved employers money and also paid employees for completing it?

The economic logic is sound. Prevention can return multiples on what it costs, and employees create that value through behavior change. Why shouldn't employees capture some of that value directly?

The emerging architecture works like this:

1. Employee completes preventive action (biometric screening, chronic disease visit, medication adherence milestone)
2. System verifies completion via claims or lab data
3. Employee receives immediate financial reward:
   • Spendable dollars for health products (not points, actual money)
   • Automatic retirement account contribution
   • Both

Unlike wellness theater with points and branded water bottles, this is a structural redesign: prevention pays employees directly, healthy behavior builds retirement wealth, and employers cut total benefits costs. Everyone's incentives align. WellthCare achieves precisely this alignment, delivering healthcare that pays employees back through store rewards and retirement contributions.

Imagine telling your employees: "Get your annual physical and we'll deposit $100 into your retirement account." That's the conversation that changes behavior, not "earn 500 points toward a chance to win a Fitbit."

The Half-Trillion-Dollar Question

Americans' out-of-pocket healthcare spending reached $556.6 billion in 2024, according to CMS. Deductibles, copays, and coinsurance make up most of that total.

What percentage of that creates clinically useful friction versus harmful barriers to necessary care?

Much of that friction is harmful:

• It delays necessary care
• It reduces preventive utilization
• It creates downstream costs that dwarf the initial savings
• It disproportionately harms lower-income workers who need care most

The waste comes from misaligned incentives, not fraud or abuse, and it produces predictably bad outcomes.

The industry has spent twenty years optimizing copay structures (should it be $20, $25, or $30?) while ignoring the bigger question:

The optimal copay for prevention may be $0, and the optimal incentive may be positive rather than negative.

What to Do Monday Morning

If you're a benefits leader reading this, here are five steps to run this week:

1. Pull 24 months of medical and Rx claims data
2. Segment your population by chronic condition
3. Calculate visit adherence rates versus copay amounts
4. Model what happens if you eliminate copays for chronic disease management
5. Project the cost impact over 36 months (not 12; you need to see the full curve)

I'll wager the math shows double-digit ROI. Probably better than 15%. Maybe better than 20%.

And when it does?

You've found real annual savings hiding behind a $30 copay. Money you are paying to make your employees sicker.

The Path Forward

Zero-copay prevention works. The clinical evidence is overwhelming, the financial models are proven, and the technology exists.

The open question is how much longer you can afford not to implement it.

Every year you wait is another year of:

• Preventable emergency room visits
• Avoidable specialty drug spend
• Unnecessary disease progression
• Employees choosing between healthcare and groceries

Modern benefits design spent decades making the wrong care cheaper and the right care more expensive, then wondered why costs kept rising.

The fix is simple, and it runs backward from everything we've been taught.

Maybe it's time to question what we've been taught.

About This Analysis: This post draws on peer-reviewed research in health economics, documented value-based insurance design programs, and published analyses of how cost-sharing affects care utilization and total cost of care. The financial models presented are illustrative estimates built on conservative assumptions. Results will vary based on population health status, existing benefit design, and implementation quality.

This article is for general information only and is not legal, tax, or medical advice. Employers should consult their own advisors.